Siriuspoint
SIRIUSPOINT LTD.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.2B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
19.6%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★★★☆position among all companies
10.1%
Capital efficiency
★★★★★position among all companies
18.6%
Revenue and profit
Performance, financial position and capital allocation
Siriuspoint
Recent performance trends
Siriuspoint
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$2.2 billion | US$2.1 billion | US$2.7 billion | US$2.6 billion | US$3.2 billion |
| Net income | US$58.10 million | US$-0.4 billion | US$0.4 billion | US$0.2 billion | US$0.5 billion |
| Total assets | US$10.6 billion | US$11.0 billion | US$12.9 billion | US$12.5 billion | US$12.6 billion |
| Shareholders' equity | US$2.5 billion | US$2.1 billion | US$2.5 billion | US$1.9 billion | US$2.5 billion |
| Net cash provided by (used in) operating activities | US$1.60 million | US$0.3 billion | US$0.6 billion | US$74.70 million | US$0.1 billion |
| Net cash provided by (used in) investing activities | US$0.2 billion | US$-1.3 billion | US$-0.3 billion | US$0.3 billion | US$0.4 billion |
| Net cash provided by (used in) financing activities | US$24.30 million | US$-23.70 million | US$-61.50 million | US$-0.6 billion | US$-0.5 billion |
| Cash and cash equivalents | US$1.0 billion | US$0.7 billion | US$1.0 billion | US$0.7 billion | US$0.7 billion |
Revenue scale in the same industry
Siriuspoint
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 48 companies
- 52 White Mountains Insurance Group US$3.7B
- 53 Primerica US$3.3B
- 54 SiriuspointThis company US$3.2B
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Cash and cash equivalents | US$0.7 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.1 billion | Consolidated | Disclosed |
| Dividends paid | US$0 | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$2.5 billion | Consolidated | Disclosed |
| Non-controlling interests | US$1.10 million | Consolidated | Disclosed |
| Net assets | US$2.5 billion | Consolidated | Disclosed |
| Net sales | US$3.2 billion | Consolidated | Disclosed |
| Net income | US$0.5 billion | Consolidated | Disclosed |
| Total assets | US$12.6 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.5 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | 19.6% | Consolidated | Calculated |
| Net margin | 14.3% | Consolidated | Calculated |
| Return on equity | 18.6% | Consolidated | Calculated |